SG/CALL/EDWARDS LIFESCIENCES/105/0.1/20.12.24 | Real-time Bid/Ask 12:55:38 2024-05-17 EDT | ||
| 0.64 EUR / 0.65 EUR | -7.86% |
|
| Current month | +16.67% | ||
| 1 month | -18.60% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 0.67 | -4.29% |
| 24-05-16 | 0.7 | +27.27% |
| 24-05-15 | 0.55 | +5.77% |
| 24-05-14 | 0.52 | -8.77% |
| 24-05-13 | 0.57 | -6.56% |
Delayed Quote Börse Stuttgart
Last update May 17, 2024 at 04:14 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SW7EQ4 |
| ISIN | DE000SW7EQ42 |
| Date issued | 2024-03-07 |
| Strike | 105 $ |
| Maturity | 2024-12-20 (217 Days) |
| Parity | 10 : 1 |
| Emission price | 0.86 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.14 € |
|---|---|
| Lowest since issue | 0.52 € |
| Spread | 0.01 € |
| Spread % | 1.54% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
90.11
USD
Average target price
95.9
USD
Spread / Average Target
+6.43%
- Stock Market
- Warrants
- Warrant